Treatment of osteoporosis in clinical practice: first experience with the Russian generic drug of zoledronic acid
Objective: to evaluate the effect of the generic drug of zoledronic acid on bone mineral density (BMD) and markers of bone metabolism in patients with osteoporosis (OP), as well as possible long-term adverse reactions (AR) 12 months after drug administration.Patients and methods. The study included...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
IMA-PRESS LLC
2022-05-01
|
| coleção: | Современная ревматология |
| Assuntos: | |
| Acesso em linha: | https://mrj.ima-press.net/mrj/article/view/1275 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|